LFVNConsumer Defensive · Packaged FoodsThe 2 Wall Street analysts covering LifeVantage Corp. hold a median 12-month price target of $7.5 — +21.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 79 of 100 as at 11 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores LifeVantage Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (14): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on LFVN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +21.6% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 28 Aug 2026 | Lake Street | Maintains | Hold | $5.00 → $6.00 |
| 7 May 2026 | Lake Street | Downgrade | Hold | $5.00 |
| 7 May 2026 | Lake Street | Downgrade | Hold | — |
| 18 Feb 2026 | Freedom Broker | Maintains | Buy | — |
| 14 Nov 2025 | Freedom Broker | Maintains | Buy | — |
| 14 Jan 2025 | Craig-Hallum | Initiates | Buy | — |
| 19 Dec 2024 | Lake Street | Initiates | Buy | — |
| 12 Feb 2014 | Imperial Capital | Initiates | In-Line | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. LFVN appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 11 Sept 2026, LifeVantage Corp. returned −45.6% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 45% of US stocks
Cheaper than 84% of US stocks
Cheaper than 39% of US stocks
Cheaper than 45% of US stocks
Higher than 10% of US stocks
Higher than 14% of US stocks
Higher than 89% of US stocks
Higher than 52% of US stocks
Higher than 54% of US stocks
Higher than 74% of US stocks
Higher than 82% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
LifeVantage Corp. has a market value of $77.3M and an enterprise value of $72.2M.
Revenue in the twelve months to 30 June 2026: $182.6M. The latest quarter shrank 23.1% year on year.
Net income over the same four quarters: $5.1M, a 2.8% net margin.
Diluted earnings per share, trailing twelve months: $0.40.
Free cash flow in the twelve months to 30 June 2026: $6.7M.
LifeVantage Corp. spent $5.7M on share buybacks and $2.3M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 15.8×; forward P/E: 16.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 3.26%, paying out 46% of earnings.
LifeVantage Corp. employs 209 people — $874K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own LifeVantage Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Seeking Alpha published a transcript of LifeVantage Corporation's Q4 2026 earnings call. The excerpt contains only the headline and source, with no details on the company's financial results or commentary.
Why it matters — A LifeVantage watcher would care because the earnings call transcript provides direct insight into the company's quarterly performance and management's outlook.
Lifevantage (LFVN) reported lower fourth-quarter and fiscal 2026 results, citing fewer orders, lower average order sizes, and a difficult comparison against prior-year sales of its MindBody GLP-1 System. The decline was discussed during the company's Q4 earnings call.
Why it matters — LFVN watchers would follow this because the company's recent financial results point to weakening demand, with declines in both order volume and order size, and the prior-year GLP-1 product sales creating a challenging comparison.
LifeVantage Corporation reported its financial results for the fourth fiscal quarter and full fiscal year 2026, covering the quarter ended June 30, 2026. The results were announced via a press release from Salt Lake City on Aug. 27, 2026.
Why it matters — LifeVantage watchers would care because this announcement provides the company's official fourth-quarter and full-year financial results, which are key indicators of its recent performance.
LifeVantage Corporation announced that its Board of Directors approved a quarterly cash dividend of $0.050 per share of common stock. The dividend will be paid on September 15, 2026 to stockholders of record at the close of business on September 1, 2026.
Why it matters — A declared cash dividend is relevant to LifeVantage watchers as it signals the company's ongoing distribution of returns to its shareholders.
LifeVantage Corporation announced it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026, and will hold a conference call for investors at 2:30 p.m. Mountain Time that same day.
Why it matters — The announcement provides LFVN watchers with the scheduled date and time for the company's fiscal year-end earnings release and investor conference call.
The 2 Wall Street analysts covering LifeVantage Corp. have a median 12-month price target of $7.5, with estimates ranging from $6 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering LifeVantage Corp., 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks LifeVantage Corp. 79 out of 100 across roughly 4,600 US stocks as at 11 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 11 Sept 2026, LifeVantage Corp. ranks 79 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +21.6% from the last close, and Ticker Nerd's factor model ranks LifeVantage Corp. 79 out of 100 as at 11 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering LifeVantage Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFVN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $6 to $9 over the next 12 months.
LifeVantage Corp. returned -45.6% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines.
The most recent item we track (Seeking Alpha, 27 Aug 2026): "LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript". Seeking Alpha published a transcript of LifeVantage Corporation's Q4 2026 earnings call. The excerpt contains only the headline and source, with no details on the company's financial results or commentary.
LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines. The company serves customers through a direct-selling model and operates across international markets in the Americas, Asia-Pacific, and Europe. LifeVantage Corporation focuses on science-based consumer health products that combine nutrition, beauty, and wellness, giving it a distinct position in the global nutritional supplements and personal care market.
CEO Mr. Terrence O. Moorehead · 209 employees · United States · https://www.lifevantage.com
